Clinical presentation
Patients with COVID19 infection exhibit a wide range of symptoms. Most cases reported have mild disease, and nearly 20% appear to progress to severe disease, including pneumonia, respiratory failure and in some cases death . Fever (98%), cough (82%), shortness of breath (55%), fatigue (70%), myalgia (44%) and sputum production (33%) are most common symptoms reported whereas less common symptoms include headache (13%), diarrhoea (10%), nausea and vomiting (10%) and haemoptysis (5%).
Term | Case definition |
Suspect Case | A patient with acute respiratory illness {fever and at least one sign/symptom of respiratory disease (e.g. cough, shortness of breath or diarrhoea), AND a history of travel to or residence in a country/area or territory reporting transmission of COVID-19 disease during the 14 days prior to symptom onset. |
A patient with acute respiratory illness {fever and at least one sign/symptom of respiratory disease (e.g. cough, shortness of breath or diarrhoea), AND a history of travel to or residence in a country/area or territory reporting transmission of COVID-19 disease during the 14 days prior to symptom onset. | |
A patient with severe acute respiratory infection {fever and at least one sign/symptom of respiratory disease (e.g. cough, shortness breath)} AND requiring hospitalization AND with no other etiology that fully explains the clinical presentation | |
A case for whom testing for COVID-19 is inconclusive | |
Lab confirmed Case | A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms. |
Contact | A contact is a person that is involved in any of the following: |
Providing direct care without proper personal protective equipment (PPE) for COVID-19 patient | |
Staying in the same close environment of a COVID-19 patient (including workplace, classroom, household, gatherings) | |
Travelling together in close proximity (within 1 m) with a symptomatic person who later tested positive for COVID-19 | |
High risk contact | Contact with a confirmed case of COVID-19 |
Travel to a province where COVID-19 LOCAL TRANSMISSION is being reported as per WHO daily situation report | |
Touched body fluids of patients (respiratory tract secretions, blood, vomitus, saliva, urine, faeces) | |
Touched or cleaned the linens, clothes or dishes of the patient | |
Close contact, within 3 feet (1 metre) of the confirmed case | |
Co-passengers in an airplane/vehicle seated in the same row, 3 rows in front and behind of a confirmed COVID-19 case | |
Low risk Contact | Shared the same space (same classroom/same room for work) or similar activity and not having high risk exposure to the confirmed/suspected case |
Travel in the same environment (bus/train/flight/any mode of transit) but not having high risk exposure as cited above | |
Any traveller from abroad not satisfying high risk criteria |
It is advised that before taking up for homoeopathic medicines for prophylaxis, Amelioration and mitigation, physician must acquaint himself of above sections.
In case of epidemics or pandemics, first approach is to follow preventive measures and educate people about general measures and to provide such interventions which will keep their immunity enhanced. Homeopathy therefore recommends issuing of public notice for Genus epidemicus identified by the designated experts for immunity enhancement and practitioners may suggest the same to the people and as per the Advisory issued by Ministry of AYUSH.
Second approach is to provide homoeopathic symptomatic mitigation to affected persons. Homoeopathic medicines are also useful in the treatment of communicable diseases like Influenza Like Illness, dengue, acute encephalitis syndrome. Several studies are also published which shows the immune modulatory potential of homoeopathic medicines in preclinical studies. These medicines can be prescribed in an integrated manner or standalone depending on the severity on a case to case
As a system with wholistic approach medicine were selected based on the presenting signs and symptoms of each patients. The medicines given here are suggestive based on their use and studies in the past in diseases of similar presentation like COVID-19. Patients of COVID-19 are to be treated with adjuvant Homoeopathic medicines with the permission from local health authorities and Medical Superintendent of the Hospital. Homoeopathic doctors must follow all preventive measures (using PPEs) as are required for dealing with COVID 19 patients.
The remedies according to different stages of disease are given below:
Mild Disease (Symptomatic Amelioration and Mitigation Approach): Medicines like Aconite napellus, Arsenicum album, Bryonia alba, Gelsemium sempervirens, Rhus tox. Eupatorium perfoliatum, Ipecacaucunha, Belladonna, Camphora,may be used depending upon the symptoms similarities.
Severe disease but not in critical condition:
It is defined by following criteria (Dyspnoea, respiratory frequency ≥ 30/min, blood oxygen saturation (SpO2) ≤ 93%, PaO2/FiO2 ratio < 300, and/or lung infiltrates > 50% within 24 to 48 hours)/)
The medicine selected for each patient is tailored to person specific, taking into consideration, his/her mental make-up, physical symptoms, and characteristic particulars etc. In case of long term illness, besides the above mentioned factors, age, occupation, previous illnesses and life circumstance unique to that individual irrespective of the disease which he/she is suffering from, are also taken into consideration; thus the dictum “Homoeopathy treats the patient but not the disease”.
After the appropriate medicine is selected, it is essential to decide the requisite potency, dose and repetition which is imperative for optimum response and faster recovery in each case. Different types of potencies such as decimal or centesimal potencies can be employed for treatment as are required for acute diseases. However, selection of potency of the remedy is dependent on various factors like susceptibility of the patient (high or low), type of disease (acute/chronic), seat/ nature and intensity of the disease, stage and duration of the disease and also the previous treatment of the disease(24).
Source : Ministry of AYUSH
Last Modified : 9/13/2023
This topic provides information related to World H...